US Regulation
PreCheck Program Expands Manufacturing
Von KI berichtet
The PreCheck program was launched to boost domestic pharmaceutical manufacturing in the US. It focuses on increasing production capacity and supply chain resilience. Regulatory developments also include blood-based tests for Alzheimer's detection.